1. Home
  2. GRFS vs RYN Comparison

GRFS vs RYN Comparison

Compare GRFS & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • RYN
  • Stock Information
  • Founded
  • GRFS 1940
  • RYN 1926
  • Country
  • GRFS Spain
  • RYN United States
  • Employees
  • GRFS N/A
  • RYN N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • RYN Real Estate Investment Trusts
  • Sector
  • GRFS Health Care
  • RYN Real Estate
  • Exchange
  • GRFS Nasdaq
  • RYN Nasdaq
  • Market Cap
  • GRFS 5.5B
  • RYN 4.5B
  • IPO Year
  • GRFS 2006
  • RYN N/A
  • Fundamental
  • Price
  • GRFS $7.27
  • RYN $26.68
  • Analyst Decision
  • GRFS Strong Sell
  • RYN Hold
  • Analyst Count
  • GRFS 1
  • RYN 3
  • Target Price
  • GRFS N/A
  • RYN $33.00
  • AVG Volume (30 Days)
  • GRFS 704.7K
  • RYN 906.8K
  • Earning Date
  • GRFS 01-01-0001
  • RYN 01-29-2025
  • Dividend Yield
  • GRFS N/A
  • RYN 11.09%
  • EPS Growth
  • GRFS N/A
  • RYN 98.46
  • EPS
  • GRFS 0.27
  • RYN 1.07
  • Revenue
  • GRFS $7,814,096,584.00
  • RYN $1,004,107,000.00
  • Revenue This Year
  • GRFS $9.31
  • RYN N/A
  • Revenue Next Year
  • GRFS $7.44
  • RYN N/A
  • P/E Ratio
  • GRFS $31.76
  • RYN $24.84
  • Revenue Growth
  • GRFS 7.21
  • RYN 20.26
  • 52 Week Low
  • GRFS $5.30
  • RYN $24.88
  • 52 Week High
  • GRFS $9.96
  • RYN $35.29
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 43.85
  • RYN 42.70
  • Support Level
  • GRFS $7.00
  • RYN $24.88
  • Resistance Level
  • GRFS $7.53
  • RYN $26.62
  • Average True Range (ATR)
  • GRFS 0.24
  • RYN 0.57
  • MACD
  • GRFS -0.01
  • RYN 0.19
  • Stochastic Oscillator
  • GRFS 27.00
  • RYN 76.14

About GRFS Grifols S.A.

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

About RYN Rayonier Inc. REIT

Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. The firm also owns timberland in New Zealand. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.

Share on Social Networks: